论文部分内容阅读
今年5月,国家监管部门在飞行检查中发现,部分制药企业为了节约成本,擅自改变银杏叶提取工艺,存在“分解药品有效成分,影响药品疗效”的风险。这一事件波及到上百家使用问题银杏叶提取物的药企,其中不乏像河南宛西、哈药、汤臣倍健、深圳海王等知名品牌,不但让银杏叶片的生产形成了困局,也让那些常年服用银杏叶片的患者摸不着头脑——到底哪种银杏叶片才能放心购买,我现在正在服用的银杏叶片存在质量问题吗?
In May this year, the state regulatory authorities found during the flight inspection that some pharmaceutical companies, in order to save costs and arbitrarily change the extraction process of Ginkgo biloba, have the risk of “decomposing the active ingredients of medicines and affecting the efficacy of medicines”. This incident spread to hundreds of pharmaceutical companies using the problem of Ginkgo biloba extract, many of them like Henan Wanxi, Harbin Pharmaceutical, Tomson times Kin, Shenzhen Neptune and other famous brands, not only for the production of ginkgo leaves formed a dilemma, but also Let those who take ginkgo leaf perennial patients puzzled - in the end what kind of ginkgo leaves can rest assured purchase, I now take the quality problems of ginkgo leaves it?